Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37276599.
- Also identified by DOI 10.7326/J23-0031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Swen JJ, van der Wouden CH, Manson LE, et al; Ubiquitous Pharmacogenetics Consortium. <b>A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.</b> Lancet. 2023;401:347-356. 36739136.
Medical subject headings
- Drug-Related Side Effects and Adverse Reactions